Alaunos TherapeuticsTCRT
13F holders, Q1 2026 (March 31)29holders +2
3new positions
2sold out
1famous investor
$2.86avg. 13F price*
At the end of Q1 2026, 29 institutions reported holding Alaunos Therapeutics Inc. (TCRT) in their 13F filings, up 2 from Q4 2025. 3 opened new positions and 2 sold out. The largest holders were Geode Capital Management, LLC ($65K), BlackRock, Inc. ($61K) and Vanguard Fiduciary Trust Co. ($44K). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Alaunos Therapeutics Inc.
- CUSIP
- 98973P309
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025 → Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $60K |
| Exits | 2 | $290 |
All 13F filers, Q4 2025 → Q1 2026: 26,609 shares bought and 8,922 shares sold, net +17,687 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 29 holders
| Geode Capital Management, LLC | 0.00% | Add +14.3% | 22,560 | $65K |
| BlackRock, Inc. | 0.00% | No change | 21,353 | $61K |
| Vanguard Fiduciary Trust Co. | 0.00% | — | 15,497 | $44K |
| Vanguard Capital Management LLC | 0.00% | — | 14,063 | $40K |
| HRT Financial LP | 0.00% | Add +5.8% | 13,327 | $38K |
| Two Sigma Investments, LP | 0.00% | Reduce -41.7% | 10,839 | $31K |
| Citadel Advisors | 0.00% | New | 10,519 | $30K |
| XTX Topco Ltd | 0.00% | New | 10,174 | $29K |
| UBS Group AG | 0.00% | Add +73.7% | 2,274 | $7K |
| Osaic Holdings, Inc. | 0.00% | Add +65.3% | 1,779 | $5K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +46.4% | 1,583 | $5K |
| Morgan Stanley | 0.00% | Reduce -60.4% | 653 | $2K |
| Vanguard Global Advisers, LLC | 0.00% | — | 501 | $1K |
| Royal Bank of Canada | 0.00% | New | 185 | $1K |
| Wells Fargo & Company | 0.00% | Add +6.7% | 190 | $543 |
| Blue Trust, Inc. | 0.00% | No change | 135 | $386 |
| Steward Partners Investment Advisory, LLC | 0.00% | No change | 92 | $263 |
| Federation des caisses Desjardins du Quebec | 0.00% | No change | 70 | $200 |
| Key Financial Inc | 0.00% | No change | 24 | $69 |
| Signaturefd, LLC | 0.00% | No change | 23 | $66 |
| NFSG Corp | 0.00% | No change | 21 | $60 |
| Lanark Financial, Inc. | 0.00% | No change | 20 | $57 |
| AdvisorNet Financial, Inc | 0.00% | No change | 19 | $54 |
| Sunbelt Securities, Inc. | 0.00% | No change | 10 | $29 |
| Inspire Investing, LLC | 0.00% | Reduce -10.0% | 9 | $25 |
| Cwm, LLC | 0.00% | No change | 8 | $23 |
| BNP Paribas Financial Markets | 0.00% | No change | 6 | $17 |
| Tidemark, LLC | 0.00% | No change | 2 | $6 |
| Citigroup Inc. | 0.00% | Reduce -98.9% | 1 | $3 |
"% of holder's portfolio" is TCRT's weight in each manager's 13F, not the share of Alaunos Therapeutics Inc. the manager owns.